financetom
Business
financetom
/
Business
/
Cognizant Q2 Adjusted Earnings Rise, Revenue Declines; 2024 EPS Guidance Lifted
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cognizant Q2 Adjusted Earnings Rise, Revenue Declines; 2024 EPS Guidance Lifted
Jul 31, 2024 1:51 PM

04:25 PM EDT, 07/31/2024 (MT Newswires) -- Cognizant Technology Solutions ( CTSH ) reported Q2 adjusted earnings late Wednesday of $1.17 per diluted share, up from $1.10 a year earlier.

Analysts polled by Capital IQ expected $1.12.

Revenue for the quarter ended June 30 was $4.85 billion, compared with $4.89 billion a year earlier. Analysts surveyed by Capital IQ expected $4.80 billion.

The company expects Q3 revenue of $4.89 billion to $4.96 billion. Analysts expect $4.91 billion.

Cognizant now expects 2024 adjusted EPS of $4.62 to $4.70 on revenue of $19.3 billion to $19.5 billion. It previously expected EPS of $4.50 to $4.68 on revenue of $18.9 billion to $19.7 billion.

Analysts are looking for 2024 normalized EPS of $4.62 on revenue of $19.4 billion.

Price: 75.64, Change: -0.04, Percent Change: -0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hudson Pacific Properties Q3 Adjusted Funds From Operations, Revenue Decrease
Hudson Pacific Properties Q3 Adjusted Funds From Operations, Revenue Decrease
Nov 5, 2025
09:24 AM EST, 11/05/2025 (MT Newswires) -- Hudson Pacific Properties ( HPP ) reported Q3 adjusted funds from operations Wednesday of $0.03 per diluted share, down from $0.11 a year earlier. Analysts polled by FactSet expected $0.02. Revenue for the quarter ended Sept. 30 was $186.6 million, down from $200.4 million a year earlier. Analysts surveyed by FactSet expected $184.3...
Perrigo begins strategic review of baby formula business
Perrigo begins strategic review of baby formula business
Nov 5, 2025
Nov 5 (Reuters) - Perrigo ( PRGO ) said on Wednesday it has initiated a strategic review of its infant formula business as the consumer health company shifts its focus to higher-margin branded products. The company is a top supplier of store-brand baby formula, which is sold under retailers' labels and can cost less than branded products. The infant formula...
Form 8.3
Form 8.3
Nov 5, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Sionna Therapeutics' Q3 Net Loss Narrows
Sionna Therapeutics' Q3 Net Loss Narrows
Nov 5, 2025
09:24 AM EST, 11/05/2025 (MT Newswires) -- Sionna Therapeutics ( SION ) reported a Q3 net loss Wednesday of $0.46 per diluted share, narrower than a loss of $5.67 a year earlier. Weighted-average diluted shares outstanding totaled 44.3 million in the quarter ended Sept. 30, up from 4.5 million a year earlier. Two analysts polled by FactSet expected a loss...
Copyright 2023-2026 - www.financetom.com All Rights Reserved